AB-400 (Anjon Biologics)

N/A

Report date: 2025/03/14 16:50:20
NME

Base Information

Drug NameAB-400 (Anjon Biologics)
Drug Alias NameAB-400
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnjon Biologics
China Registration ClassN/A

Develop Information

Active CompaniesAnjon Biologics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A